Document Classification

Section Type: RESULTS

Text: For the dose-density comparison, disease-free survival at 5 years was 81 % (95 % CI 79-84) in patients treated every 2 weeks and 76 % (74-79) in patients treated every 3 weeks (HR 077, 95 % CI 065-092 ; p = 0004) ; overall survival rates at 5 years were 94 % (93-96) and 89 % (87-91 ; HR 065, 051-084 ; p = 0001) and for the chemotherapy-type comparison, disease-free survival at 5 years was 78 % (75-81) in the FEC-P groups and 79 % (76-82) in the EC-P groups (HR 106, 089-125 ; p = 0561) ; overall survival rates at 5 years were 91 % (89-93) and 92 % (90-94 ; 116, 091-146 ; p = 0234).